Literature DB >> 33474649

Implementation of an Inpatient IBD Service Is Associated with Improvement in Quality of Care and Long-Term Outcomes.

Simon J Hong1, Janice Jang2, Dana Berg2, Tarik Kirat2, Feza Remzi2, Shannon Chang2, Lisa B Malter2, Jordan E Axelrad2, David P Hudesman2.   

Abstract

BACKGROUND: There is wide variation in the quality of care of hospitalized patients with inflammatory bowel disease (IBD). Prior studies have demonstrated that a specialized inpatient IBD service improves short-term outcomes. In this study, we assessed the impact of a dedicated IBD service on the quality of care and long-term outcomes.
METHODS: This retrospective cohort study included adult patients admitted for a complication of IBD between March 2017 and February 2019 to a tertiary referral center. In March 2018, a dedicated inpatient IBD service co-managed by IBD gastroenterologists and colorectal surgeons was implemented. Quality of care outcomes included C. difficile stool testing, confirmed VTE prophylaxis administration and opiate avoidance. Long-term outcomes were clinical remission, IBD-related surgery, ED visits, and hospital readmissions at 90 days and 12 months.
RESULTS: In total, 143 patients were included; 66 pre- and 77 post-implementation of the IBD service. Fifty-two percent had ulcerative colitis and 48% had Crohn's disease. After implementation, there was improvement in C.difficile testing (90% vs. 76%, P = 0.04), early VTE prophylaxis (92% vs. 77%, P = 0.01) and decreases in narcotic use (14% vs. 30%, P = 0.02), IBD-related ED visits at 90 days (7% vs 18%, P = 0.03) and 12 months (16% vs 30%, P = 0.04), and IBD readmissions at 90 days (16% vs. 30%, P = 0.04). There were no differences in rates of clinical remission or surgery.
CONCLUSIONS: The creation of a dedicated inpatient IBD service improved quality of IBD care and reduced post-discharge ED visits and readmissions and broader implementation of this strategy may help optimize care of hospitalized IBD patients.

Entities:  

Keywords:  Inflammatory bowel disease; Inpatient; Outcomes; Quality of care

Year:  2021        PMID: 33474649     DOI: 10.1007/s10620-020-06749-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  2 in total

1.  Inflammatory bowel disease readmissions are associated with utilization and comorbidity.

Authors:  Shirley Cohen-Mekelburg; Russell Rosenblatt; Beth Wallace; Nicole Shen; Brett Fortune; Akbar K Waljee; Sameer Saini; Ellen Scherl; Robert Burakoff; Mark Unruh
Journal:  Am J Manag Care       Date:  2019-10       Impact factor: 2.229

2.  The Impact of Opioid Epidemic Trends on Hospitalised Inflammatory Bowel Disease Patients.

Authors:  Shirley Cohen-Mekelburg; Russell Rosenblatt; Stephanie Gold; Robert Burakoff; Akbar K Waljee; Sameer Saini; Bruce R Schackman; Ellen Scherl; Carl Crawford
Journal:  J Crohns Colitis       Date:  2018-08-29       Impact factor: 9.071

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.